At MediMix, we are dedicated to keeping Belgian healthcare professionals at the forefront of medicine. Our team brings you high-value insights from leading congresses worldwide, across key disease areas including hematology. In collaboration with Belgian and international experts, we transform the latest data into practical knowledge.
In this video, Prof Dr Fredrik Schjesvold summarizes findings from two posters he presented at the 2026 Annual Meeting of the International Myeloma Society (IMS) in Glasgow, both examining aspects
In this video, Dr Arthur Bobin summarizes data from a poster he presented at the 2026 Annual Meeting of the International Myeloma Society (IMS) in Glasgow. The analysis compared subcutaneous
Prof Dr Luciano Costa takes a closer look at additional survival analyses from a phase III trial in previously treated multiple myeloma.
In this video, Dr Sina Beer describes a subgroup analysis of the OPTIMUM/MUKnine trial presented at the 2026 Annual Meeting of the International Myeloma Society (IMS) in Glasgow.
In this video, Lien Ann Van Hemelrijck summarizes her research on the role of methionine adenosyltransferase 2A (MAT2A) in multiple myeloma. MAT2A produces S-adenosylmethionine (SAM), a major methyl donor, and
In this video, Prof Dr Xavier Leleu discusses updated survival data from the BENEFIT study presented at the 2026 Annual Meeting of the International Myeloma Society (IMS) in Glasgow. The
In this video, Prof Dr María-Victoria Mateos discusses results from the phase III CERVINO trial presented at the 2026 Annual Meeting of the International Myeloma Society (IMS) in Glasgow. This
In this daily highlights video from IMS 2026 in Glasgow Dr Nicolas Kint reflects on key highlights from the meeting regarding innovative treatment strategies. Against a backdrop of increasingly deep
Explore the latest conference highlights, expert insights and podcasts, all in the MediMix app.
Explore the latest conference highlights, expert insights and podcasts, all in the MediMix app.
